Search Within

GME, Medicine

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (146)
  2. Journal Article (143)
  3. Research Letter (8)
  4. Review (4)
  5. Editorial (3)
Groups
  1. Graduate Medical Education (304)
  2. Human Oncology and Pathogenesis Program (304)
  3. GSK Faculty (300)
  4. Department of Medicine (290)
  5. Hematology-Oncology Fellows (247)
  6. Solid Tumor Oncology Division (202)

More Groups

People
  1. Michael Berger (67)
  2. Nikolaus Schultz (53)
  3. Marc Ladanyi (48)
  4. Marcel Van Den Brink (40)
  5. David Solit (35)
  6. Santosha Vardhana (34)

More People

Years
  1. 2025 (21)
  2. 2024 (75)
  3. 2023 (81)
  4. 2022 (53)
  5. 2021 (17)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Blood (31)
  3. Clinical Cancer Research (20)
  4. Cancer Research (17)
  5. Annals of Oncology (12)
  6. JCO Precision Oncology (10)

More Publications

Publishers
  1. American Society of Clinical Oncology (78)
  2. American Association for Cancer Research (45)
  3. American Society of Hematology (35)
  4. Elsevier Inc. (29)
  5. Nature Publishing Group (24)
  6. Oxford University Press (24)

More Publishers

Results (304)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gestational trophoblastic neoplasm: Patient outcomes and clinical pearls from a multidisciplinary referral center
    Journal Article

    Liu, Y. L.; Praiss, A. M.; Chiang, S.; Devereaux, K.; Huang, J.; Rizzuto, G.; Al-Rawi, D.; Weigelt, B.; Jewell, E.; Abu-Rustum, N. R.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Efficacy and safety profile of mirvetuximab in folate receptor alpha-positive ovarian cancer
    Meeting Abstract

    Johannet, P.; Foote, M.; Cohen, S.; Friedman, C.; Green, A.; Guo, R.; Hensley, M.; Konner, J.; Kyi, C.; Liu, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas
    Meeting Abstract

    Rosenbaum, E.; Ehrich, F.; Bradic, M.; Kelly, C. M.; Movva, S.; Chan, J.; Chi, P.; Banks, L.; Dickson, M.; Keohan, M. L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A retrospective single-center study of outcomes to immune checkpoint blockade-based therapy in leiomyosarcoma
    Meeting Abstract

    Babatunde, O.; Rosenbaum, E.; Kelly, C. M.; Desir-Camille, R.; Keohan, M. L.; Banks, L.; Avutu, V.; Chan, J.; Reed, D.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of broad-spectrum antibiotic exposure on CAR-T therapy outcomes in B-cell lymphoma: A multicenter international study
    Meeting Abstract

    Shouval, R.; Fei, T.; Gabrielli, G.; Smith, N. G.; Ghilardi, G.; Slingerland, J.; Peled, J. U.; Taur, Y.; Nasta, S. D.; Luna, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Dual-vector-transduction with single-step magnetic selection (Zip-sort) increases transgenic payloads to enhance CAR T cell activity
    Meeting Abstract

    James, S. E.; Chen, S.; Ng, B.; Fischman, J.; Jahn, L.; Boardman, A. P.; Rajagopalan, A.; Elias, H. K.; Massa, A. R.; Manuele, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world experience with circulating tumor DNA in cerebrospinal fluid in patients with central nervous system tumors
    Meeting Abstract

    Hickman, R.; Miller, A. M.; Holle, B. M.; Jee, J.; Liu, S. Y.; Ross, D.; Yu, H.; Riely, G. J.; Ombres, C.; Gerwitz, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Prognostic implications of cerebrospinal fluid circulating tumor DNA (CSF ctDNA) following radiation therapy in patients with leptomeningeal metastasis: Analysis of a randomized phase II trial
    Meeting Abstract

    Goglia, A. G.; Yang, J. T.; Kratochvil, L. B.; Yerramilli, D.; Higginson, D. S.; Miller, A.; Berger, M.; Powell, S. N.; Boire, A.; Wijetunga, N. A.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save